ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

61 hedge funds and large institutions have $8.79M invested in Oncternal Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$65K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$649K
2
+$300K
3
+$183K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$143K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$112K

Top Sellers

1
-$1.29M
2
-$635K
3
-$334K
4
Goldman Sachs
Goldman Sachs
New York
-$161K
5
UBS Group
UBS Group
Switzerland
-$135K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$5K
52
$4K
53
$4K
54
$3.98K
55
$2K
56
$1K
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
1 2
3